Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
September 02 2020 - 4:15PM
Business Wire
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine
company, announced today that management will present at the
following investor conferences:
- Wells Fargo 2020 Virtual Healthcare Conference
Presentation Date: Thursday, September 10th at 3:20 p.m. Eastern
Time
- Cantor Virtual Global Healthcare Conference Presentation
Date: Tuesday, September 15th at 3:20 p.m. Eastern Time
- Morgan Stanley 18th Annual Global Healthcare Conference
Presentation Date: Friday, September 18th at 8:00 a.m. Eastern
Time
Presentations will be webcast live and may be accessed via a
link on the Sangamo Therapeutics website in the Investors and Media
section under Events and Presentations. The presentation will also
be available on the Sangamo website after the event.
About Sangamo Therapeutics
Sangamo Therapeutics is committed to translating ground-breaking
science into genomic medicines with the potential to transform
patients’ lives using gene therapy, ex vivo gene-edited cell
therapy, and in vivo genome editing and genome regulation. For more
information about Sangamo, visit www.sangamo.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200902005806/en/
Investor Relations – Global McDavid
Stilwell 510-970-6000, x219 mstilwell@sangamo.com
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Apr 2023 to Apr 2024